Controlled |
- substance possession, when conviction may be sealed - HB 276
|
- substances, data sharing - HB 26: SFA(6)
|
- substances, data sharing of - HB 26: SFA(7)
|
- substances, dispensing requirements for - HB 26: SFA(8)
|
- substances, real-time electronic monitoring, pilot study of - HB 26: SCS
|
- substances, reporting requirements - HB 26: SFA(8)
|
- substances, reporting requirements for - HB 26: SCS, SFA (3)
|
Health |
- department, abortion, prohibition against dispensing medication or device causing - HB 67: HFA(3),(4)
|
- departments, nurses dispensing in - HB 67; HB 67: SCS, HCS, HFA (1)
|
- insurance, contraceptive devices and services, coverage for - HB 778
|
- insurance, mail order prescriptions, requirements for - HB 369: HFA(2),(11)
|
- insurance, state employees, mail order option - HB 369: HFA(20)
|
Mail |
- order prescriptions, controlled substances, certified mail required for - HB 369: HFA(26)
|
- order prescriptions, controlled substances, restrictions on - HB 369: HFA(25)
|
- order prescriptions, pharmacist, requirements for - HB 369: HFA(27)
|
- order prescriptions, requirements for - HB 369: HFA(1),(3),(4),(10),(19)
|
Medicaid, |
|
- deaf-blind waiver, application for - HB 362
|
- drug manufacturers, negotiations with - HB 664
|
- drugs, reform of nonprior authorization process for - HB 60, 72
|
- outpatient drug program, pharmacies, study of costs experienced by - HB 170: SCS
|
- outpatient pharmacy program, prior authorization process for - HB 103: HFA(1)
|
|
- pharmacy and therapeutics committee, membership of - HB 103: SFA(4)
|
- pharmacy and therapeutics committee, Senate confirmation of - HB 103: SFA(3)
|
|
Prescription |
- drug costs, strategies to lower cost of - HB 160
|
- drug coverage for low income residents, Medicaid, waiver for - HB 819: HFA(2)
|
- drug coverage for seniors, creation of - SB 251
|
- drug coverage for seniors, study of - SCR 185
|
- drug coverage, requirements for. - HB 16
|
- drug discount program, establishment of - HB 158
|
- drug fund, funded with prescription drug fund fee - HB 819: HFA(3)
|